코골이 방지 기기 시장 : 장치 유형별, 성별, 연령층별, 유통 채널별, 최종 사용자별, 지역별 - 세계 예측(-2029년)

Global Anti-Snoring Devices Market Size is estimated to be about USD 0.91 Billion in 2024 and estimated to reach about USD 1.45 Billion by the year 2029, at a growth rate of CAGR of 9.8% during the forecasted period.

The market is projected to expand due to the increasing prevalence of sleep disorders such as sleep apnea, advancements in sleep therapy technologies, and the growing elderly population, which often faces a higher risk of chronic diseases. However, growth may be constrained by the high costs associated with oral sleep appliances and the complexity of referral processes.

Efforts led by government health initiatives and public awareness campaigns addressing sleep disorders are driving market growth further. Moreover, innovations in oral appliance technology and improved comfort features are enhancing patient compliance, encouraging adoption. Despite these positive factors, challenges like expensive devices and complicated diagnostic pathways may slow the growth rate. Nonetheless, the market is set to progress steadily, driven by a stronger focus on sleep health and greater accessibility to advanced treatment solutions.

"The oral appliances segment accounted for the largest share of the market in 2023, by device type."

The anti-snoring devices market, categorized by device type, includes oral appliances, nasal devices, position control devices, chin straps, and EPAP therapy devices. In 2023, oral appliances held the largest market share, primarily due to the growing popularity of mandibular advancement devices (MADs). This dominance is supported by extensive research demonstrating their superior effectiveness compared to other anti-snoring solutions.

"Home care settings segment dominated the anti-snoring devices market in 2023, based on end user."

Based on end users, the anti-snoring devices market is segmented into home care settings and hospitals & clinics. The home care settings segment accounted for the largest share of the anti-snoring devices market in 2023. The large share of this segment can be attributed to the increasing patient preference for home sleep testing and the growing number of advanced home sleep care devices available in the market. "Asia Pacific: The fastest-growing region in Anti-snoring devices market."

The worldwide market for Anti-snoring devices is categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Notably, the Asia Pacific region is anticipated to experience the most substantial growth in the forecast period. Due to the high prevalence of symptomatic OSA among middle-aged men and women, the anti-snoring devices market in several Asia Pacific countries is expected to witness high growth during the forecast period.

The large patient pool and population of undiagnosed patients indicate a massive potential for the Asia Pacific anti-snoring devices market. The regional and leading players have collaborated, signed several deals, and expanded their presence. Another major growth driver of this segment in the Anti-snoring devices market is the increasing healthcare expenditure, along with supportive regulatory frameworks. All these factors propel increased growth of the Anti-snoring devices market in the Asia Pacific region.

The break-up of the profile of primary participants in the Anti-snoring devices market:

• By Company Type: Tier 1 - 55%, Tier 2 - 25%, and Tier 3 - 20%
• By Designation: M-level - 30%, D-level - 50%, and Others - 20%
• By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America - 6%, and Middle East & Africa- 2%, GCC Countries - 2% (Others-4%)

The key players in this market are are ResMed (US), SomnoMed (Australia), ProSomnus Sleep Technologies (US), and Vivos Therapeutics, Inc. (US), DynaFlex (US), OpenAirway (Canada), Panthera Dental (Canada), Airway Management (US), Apnea Sciences (US), OravanOSA (US), Myerson LLC. (US), Braebon Medical Corporation (Canada), MPowrx Health and Wellness Products (Canada), The Snore Reliever Company, LLC (US), Tomed GmbH (Germany), The Aurum Group (Canada), OSCIMED SA (Switzerland), SICAT GmbH & Co. KG (Germany), Glidewell (US), ApnoMed, Inc. (US), ZQuiet (US), among others.

Research Coverage:

• This research report categorizes the Anti-snoring devices market by device type (Mandibular Advancement Devices, Tongue-retaining Devices, Nasal Devices, Position Control Devices, Chin Straps, EPAP Therapy Devices ), by gender (male, female), by age (below 40, between 40 to 60, above 60), by distribution channel(online, retail, hospital), by end user (home care settings, hospitals & clinics), and region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa and GCC Countries). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the Anti-snoring devices market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, key strategies, acquisitions, and agreements. New product & service launches, and recent developments associated with the Anti-snoring devices market. Competitive analysis of upcoming startups in the Anti-snoring devices market ecosystem is covered in this report.

Reasons to buy this report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall Anti-snoring devices market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

• Analysis of key drivers (rising incidence of OSA and snoring population, and increased sleep devices technologies ) opportunities (Growth opportunities in emerging economies), restraints (high cost of devices, Unfavorable reimbursement scenario), and challenges (changing regulatory landscape) influencing the growth of the Anti-snoring devices market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the Anti-snoring devices market.
• Market Development: Comprehensive information about lucrative markets - the report analyses the Anti-snoring devices market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Anti-snoring devices market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings of leading players like ResMed (US), SomnoMed (Australia), ProSomnus Sleep Technologies (US), and Vivos Therapeutics, Inc. (US), DynaFlex (US).

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 MARKET SCOPE
  • 1.3.1 MARKET SEGMENTATION
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS
• 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Primary sources
    • 2.1.2.2 Key industry insights
    • 2.1.2.3 Key data from primary sources
    • 2.1.2.4 Breakdown of primary interviews
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.1.1 Approach 1: Company revenue estimation approach
    • 2.2.1.2 Approach 2: Presentations of companies and primary interviews
    • 2.2.1.3 Approach 3: Patient-based approach
    • 2.2.1.4 Growth forecast
    • 2.2.1.5 CAGR projections
  • 2.2.2 TOP-DOWN APPROACH
• 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
• 2.4 MARKET SHARE ASSUMPTIONS
• 2.5 STUDY ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
• 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 ANTI-SNORING DEVICES MARKET OVERVIEW
• 4.2 GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Growing prevalence of sleep disorders
    • 5.2.1.2 Increasing geriatric population and subsequent rise in obesity
    • 5.2.1.3 Growing cigarette & alcohol consumption
    • 5.2.1.4 Rising technological advancements in anti-snoring devices
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High price of customized oral appliances
    • 5.2.2.2 Unreliable efficacy and inadequate studies for utilization of anti-snoring devices
    • 5.2.2.3 Social stigma associated with snoring
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Expanding undiagnosed population
    • 5.2.3.2 High growth potential of emerging markets
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Complex referral pathways and long waiting periods
• 5.3 PRICING ANALYSIS
  • 5.3.1 AVERAGE SELLING PRICE OF ANTI-SNORING DEVICES, BY KEY PLAYER
  • 5.3.2 AVERAGE SELLING PRICE TREND, BY DEVICE TYPE, 2021-2023
  • 5.3.3 AVERAGE SELLING PRICE TREND OF ANTI-SNORING DEVICES (ORAL APPLIANCES), BY REGION, 2021-2023 (USD)
• 5.4 VALUE CHAIN ANALYSIS
• 5.5 SUPPLY CHAIN ANALYSIS
• 5.6 ECOSYSTEM ANALYSIS
  • 5.6.1 ANTI-SNORING DEVICES MARKET: ROLE IN ECOSYSTEM
• 5.7 PORTER'S FIVE FORCES ANALYSIS
  • 5.7.1 THREAT OF NEW ENTRANTS
  • 5.7.2 THREAT OF SUBSTITUTES
  • 5.7.3 BARGAINING POWER OF SUPPLIERS
  • 5.7.4 BARGAINING POWER OF BUYERS
  • 5.7.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.8 REGULATORY ANALYSIS
  • 5.8.1 REGULATORY LANDSCAPE
    • 5.8.1.1 North America
      • 5.8.1.1.1 US
        • 5.8.1.1.1.1 Reimbursement scenario in US
      • 5.8.1.1.2 Canada
    • 5.8.1.2 Europe
    • 5.8.1.3 Asia Pacific
      • 5.8.1.3.1 Japan
      • 5.8.1.3.2 China
      • 5.8.1.3.3 India
      • 5.8.1.3.4 Australia
  • 5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.8.2.1 North America
    • 5.8.2.2 Europe
    • 5.8.2.3 Asia Pacific
    • 5.8.2.4 Latin America
    • 5.8.2.5 Middle East & Africa
• 5.9 TECHNOLOGY ANALYSIS
  • 5.9.1 KEY TECHNOLOGIES
    • 5.9.1.1 Mandibular advancement devices
  • 5.9.2 ADJACENT TECHNOLOGIES
    • 5.9.2.1 Daytime-nighttime appliances
• 5.10 TRADE ANALYSIS
  • 5.10.1 IMPORT DATA FOR HS CODE 901849, BY COUNTRY, 2019-2023 (USD MILLION)
  • 5.10.2 EXPORT DATA FOR HS CODE 901849, BY COUNTRY, 2019-2023 (USD MILLION)
• 5.11 PATENT ANALYSIS
• 5.12 KEY CONFERENCES & EVENTS, 2024-2025
• 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.14 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.14.2 BUYING CRITERIA
• 5.15 IMPACT OF AI/GENERATIVE AI ON ANTI-SNORING DEVICES MARKET
• 5.16 INVESTMENT & FUNDING SCENARIO
• 5.17 CASE STUDY ANALYSIS

6 ANTI-SNORING DEVICES MARKET, BY DEVICE TYPE

• 6.1 INTRODUCTION
• 6.2 ORAL APPLIANCES
  • 6.2.1 MANDIBULAR ADVANCEMENT DEVICES
    • 6.2.1.1 Ready-made mandibular advancement devices
      • 6.2.1.1.1 Low cost to fuel uptake
    • 6.2.1.2 Custom-made mandibular advancement devices
      • 6.2.1.2.1 High efficacy to drive market
• 6.3 TONGUE-RETAINING/STABILIZING DEVICES
  • 6.3.1 LOWER SUCCESS RATE OF TRDS TO RESTRAIN MARKET
• 6.4 NASAL DEVICES
  • 6.4.1 EXTERNAL NASAL DILATORS
    • 6.4.1.1 Convenient and non-invasive benefits to boost demand
  • 6.4.2 OTHER NASAL DEVICES
• 6.5 POSITION CONTROL DEVICES
• 6.6 CHIN STRAPS
• 6.7 EPAP THERAPY DEVICES

7 ANTI-SNORING DEVICES MARKET, BY GENDER

• 7.1 INTRODUCTION
• 7.2 MALE PATIENTS
  • 7.2.1 HIGHER PREVALENCE OF OSA OWING TO ANATOMY VARIATIONS TO PROPEL MARKET
• 7.3 FEMALE PATIENTS
  • 7.3.1 RISING CASES OF UNDIAGNOSED OSA TO DRIVE MARKET

8 ANTI-SNORING DEVICES MARKET, BY AGE GROUP

• 8.1 INTRODUCTION
• 8.2 BELOW 40 YEARS
  • 8.2.1 LOW PREVALENCE OF OSA AMONG YOUNGER INDIVIDUALS TO RESTRAIN MARKET
• 8.3 BETWEEN 40-60 YEARS
  • 8.3.1 INCREASING INCIDENCE OF CVD AND HYPERTENSION TO PROPEL MARKET
• 8.4 ABOVE 60 YEARS
  • 8.4.1 CHANGING SLEEPING PATTERNS TO SUPPORT MARKET GROWTH

9 ANTI-SNORING DEVICES MARKET, BY DISTRIBUTION CHANNEL

• 9.1 INTRODUCTION
• 9.2 ONLINE PHARMACIES
  • 9.2.1 GROWING PREFERENCE FOR DIRECT DISTRIBUTION CHANNELS TO DRIVE MARKET
• 9.3 RETAIL PHARMACIES
  • 9.3.1 CONVENIENT ACCESSIBILITY TO PRODUCTS TO PROPEL MARKET
• 9.4 HOSPITAL PHARMACIES
  • 9.4.1 GROWING FOCUS ON PATIENT CONVENIENCE TO FUEL UPTAKE

10 ANTI-SNORING DEVICES MARKET, BY END USER

• 10.1 INTRODUCTION
• 10.2 HOME CARE SETTINGS
  • 10.2.1 GROWING PATIENT PREFERENCE FOR ADVANCED SLEEP MONITORING DEVICES TO PROPEL MARKET
• 10.3 HOSPITALS & CLINICS
  • 10.3.1 RAPID DEVELOPMENT IN HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET

11 ANTI-SNORING DEVICES MARKET, BY REGION

• 11.1 INTRODUCTION
• 11.2 NORTH AMERICA
  • 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 11.2.2 US
    • 11.2.2.1 Rising trend of remote sleep testing to fuel uptake
  • 11.2.3 CANADA
    • 11.2.3.1 Increasing number of research grants for sleep apnea devices to boost demand
• 11.3 EUROPE
  • 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 11.3.2 GERMANY
    • 11.3.2.1 High prevalence of smoking to boost demand
  • 11.3.3 UK
    • 11.3.3.1 Rising awareness and increasing number of sleep service groups to support market growth
  • 11.3.4 FRANCE
    • 11.3.4.1 Rising geriatric population to fuel uptake
  • 11.3.5 ITALY
    • 11.3.5.1 Favorable initiatives for treatment of OSA to support market growth
  • 11.3.6 SPAIN
    • 11.3.6.1 Increasing initiatives for social awareness by regional organizations for treatment to drive market
  • 11.3.7 REST OF EUROPE
• 11.4 ASIA PACIFIC
  • 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 11.4.2 CHINA
    • 11.4.2.1 Growing adult obesity rates and expanding geriatric population to propel market
  • 11.4.3 JAPAN
    • 11.4.3.1 Rising demand for cloud-connected OSA therapy devices to boost demand
  • 11.4.4 AUSTRALIA
    • 11.4.4.1 Rising R&D initiatives for innovative sleep therapy devices to boost demand
  • 11.4.5 REST OF ASIA PACIFIC
• 11.5 LATIN AMERICA
  • 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 11.5.2 BRAZIL
    • 11.5.2.1 Favorable reimbursement policies for advanced sleep apnea procedures to drive market
  • 11.5.3 MEXICO
    • 11.5.3.1 Poor healthcare infrastructure to limit market growth
  • 11.5.4 REST OF LATIN AMERICA
• 11.6 MIDDLE EAST & AFRICA
  • 11.6.1 PRESENCE OF GLOBAL PLAYERS AND HIGH INCIDENCE OF CHRONIC DISEASES TO DRIVE MARKET
  • 11.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
• 11.7 GCC COUNTRIES
  • 11.7.1 HIGH OBESITY RATES TO SUPPORT MARKET GROWTH
  • 11.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES

12 COMPETITIVE LANDSCAPE

• 12.1 OVERVIEW
• 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ANTI-SNORING DEVICES MARKET
• 12.3 REVENUE ANALYSIS, 2019-2023
• 12.4 MARKET SHARE ANALYSIS, 2023
  • 12.4.1 RANKING OF KEY MARKET PLAYERS
• 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 12.5.1 STARS
  • 12.5.2 EMERGING LEADERS
  • 12.5.3 PERVASIVE PLAYERS
  • 12.5.4 PARTICIPANTS
  • 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 12.5.5.1 Company footprint
    • 12.5.5.2 Region footprint
    • 12.5.5.3 Device footprint
    • 12.5.5.4 Distribution channel footprint
    • 12.5.5.5 End-user footprint
• 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 12.6.1 PROGRESSIVE COMPANIES
  • 12.6.2 RESPONSIVE COMPANIES
  • 12.6.3 DYNAMIC COMPANIES
  • 12.6.4 STARTING BLOCKS
  • 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
• 12.7 COMPANY VALUATION & FINANCIAL METRICS
  • 12.7.1 FINANCIAL METRICS
  • 12.7.2 COMPANY VALUATION
• 12.8 BRAND/PRODUCT COMPARISON
• 12.9 COMPETITIVE SCENARIO
  • 12.9.1 PRODUCT LAUNCHES & APPROVALS
  • 12.9.2 DEALS
  • 12.9.3 EXPANSIONS
  • 12.9.4 OTHER DEVELOPMENTS

13 COMPANY PROFILES

• 13.1 KEY PLAYERS
  • 13.1.1 RESMED
    • 13.1.1.1 Business overview
    • 13.1.1.2 Products offered
    • 13.1.1.3 Recent developments
      • 13.1.1.3.1 Deals
      • 13.1.1.3.2 Expansions
    • 13.1.1.4 MnM view
      • 13.1.1.4.1 Key strengths
      • 13.1.1.4.2 Strategic choices
      • 13.1.1.4.3 Weaknesses & competitive threats
  • 13.1.2 SOMNOMED
    • 13.1.2.1 Business overview
    • 13.1.2.2 Products offered
    • 13.1.2.3 MnM view
      • 13.1.2.3.1 Key strengths
      • 13.1.2.3.2 Strategic choices
      • 13.1.2.3.3 Weaknesses & competitive threats
  • 13.1.3 PROSOMNUS SLEEP TECHNOLOGIES
    • 13.1.3.1 Business overview
    • 13.1.3.2 Products offered
    • 13.1.3.3 Recent developments
      • 13.1.3.3.1 Deals
    • 13.1.3.4 MnM view
      • 13.1.3.4.1 Key strengths
      • 13.1.3.4.2 Strategic choices
      • 13.1.3.4.3 Weaknesses & competitive threats
  • 13.1.4 VIVOS THERAPEUTICS, INC.
    • 13.1.4.1 Business overview
    • 13.1.4.2 Products offered
    • 13.1.4.3 Recent developments
      • 13.1.4.3.1 Product approvals
      • 13.1.4.3.2 Deals
      • 13.1.4.3.3 Expansions
      • 13.1.4.3.4 Other developments
  • 13.1.5 DYNAFLEX
    • 13.1.5.1 Business overview
    • 13.1.5.2 Products offered
    • 13.1.5.3 Recent developments
      • 13.1.5.3.1 Deals
  • 13.1.6 OPENAIRWAY
    • 13.1.6.1 Business overview
    • 13.1.6.2 Products offered
    • 13.1.6.3 Recent developments
      • 13.1.6.3.1 Deals
  • 13.1.7 PANTHERA DENTAL
    • 13.1.7.1 Business overview
    • 13.1.7.2 Products offered
    • 13.1.7.3 Recent developments
      • 13.1.7.3.1 Product launches
      • 13.1.7.3.2 Deals
      • 13.1.7.3.3 Other developments
  • 13.1.8 AIRWAY MANAGEMENT
    • 13.1.8.1 Business overview
    • 13.1.8.2 Products offered
    • 13.1.8.3 Recent developments
      • 13.1.8.3.1 Product launches
  • 13.1.9 APNEA SCIENCES
    • 13.1.9.1 Business overview
    • 13.1.9.2 Products offered
  • 13.1.10 ORAVANOSA
    • 13.1.10.1 Business overview
    • 13.1.10.2 Products offered
  • 13.1.11 MYERSON LLC
    • 13.1.11.1 Business overview
    • 13.1.11.2 Products offered
  • 13.1.12 BRAEBON MEDICAL CORPORATION
    • 13.1.12.1 Business overview
    • 13.1.12.2 Products offered
• 13.2 OTHER PLAYERS
  • 13.2.1 MPOWRX HEALTH & WELLNESS PRODUCTS
  • 13.2.2 THE SNORE RELIEVER COMPANY, LLC
  • 13.2.3 TOMED GMBH
  • 13.2.4 THE AURUM GROUP
  • 13.2.5 OSCIMED SA
  • 13.2.6 SICAT GMBH & CO. KG
  • 13.2.7 GLIDEWELL
  • 13.2.8 APNOMED, INC.
  • 13.2.9 ZQUIET
  • 13.2.10 DREAM SYSTEMS DENTAL SLEEP LAB
  • 13.2.11 PURE SLEEP COMPANY
  • 13.2.12 THERAVENT, INC.
  • 13.2.13 INNOVATIVE HEALTH TECHNOLOGIES

14 APPENDIX

• 14.1 DISCUSSION GUIDE
• 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 14.3 CUSTOMIZATION OPTIONS
• 14.4 RELATED REPORTS
• 14.5 AUTHOR DETAILS